Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature

Author： Naci Huseyin  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.5, 2010-05, pp. : 363-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Burden of Haematological Adverse Effects in Cancer Patients: A Systematic Review

By Liou S.Y.   Stephens J.M.  

Clinical Drug Investigation, Vol. 27, Iss. 6, 2007-01 ,pp. : 381-396

Adis International

Access to resources Recommend Favorite

Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness

By Clegg A.   Bryant J.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 623-639

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review

By Koeser Leonardo   McCrone Paul  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 171-182

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluations of Treatments for Systemic Fungal Infections: A Systematic Review of the Literature

By Dixon S.  

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 421-433

Adis International

Access to resources Recommend Favorite

Benefit Valuation in Economic Evaluation of Cancer Therapies: A Systematic Review of the Published Literature

By Brown J.  

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 17-31

Adis International

Access to resources Recommend Favorite